Atlas Biotech & Life Sciences

Country/Region: India     State/Province: New Delhi

Main Products: Methoxsalen, Methoxsalen

Company Introduction
Our Methoxsalen goes through a top-notch quality analysis system supervised by skilled quality auditors who assess different products at different level. We have developed a state-of-the-art facility located in NEW DELHI, , India, laced with all the required amenities to keep the Methoxsalen quality consistent and maintained. Buyers can reach us for acquiring first in class Methoxsalen, as we are enlisted among best in class Manufacturers since 2007.Entire product line from Atlas Biotech & Life Sciences Private Limited are made available in different variations with quality commitments that has no match, making our Methoxsalen and Methoxsalen highly demanded in the international market. Owing to which our export ratio value has reached US$50 Million - US$100 Million based on Australia,Canada,Germany,France,United Kingdom market share. Being a quality-conscious entity and a leading Exporter of Methoxsalen, we make sure that all our products perfectly comply with the laid industry standards and boast supreme quality. This approach throughout our 13 Years of export history led us to acquire Approx More Than 1 Billion US Dollar of yearly output.Our professional enterprise was first launched with US$1 Million - US$2.5 Million of initial investment under Third Party.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2007, 2007

Legal Status: Third Party

Ownership: Private Limited

Employees: Above 1000 People

Factory Size: Below 1, 000 square meters

R&D Team Size: 51 - 100 People

Certifications: OHSAS18001

Contact Information

Contact Person: Sushanta

Designation: Director

Department: GM

Telephone: 91919819000000

Business Information

Main Markets: Australia (27%) United Kingdom (19%) Germany (16%) Canada (16%) France (15%)

Export Focus: Australia, Canada, Germany, France, United Kingdom

Contract Services: Buyer Label Offered

Trade & Financial Information

Annual Revenue: Approx More Than 1 Billion US Dollar

Registered Capital: US$1 Million - US$2.5 Million

Export Percentage: 31% - 40%

Payment Terms: Bank wire (T/T)

Product Showcase
Methoxsalen
Methoxsalen

CL-Link > Health & Medicines in India Health & Medicines in New Delhi Medicines in India Medicines in New Delhi Methoxsalen in India Methoxsalen in New Delhi